Melanoma: age, insurance among factors for surgical delay

  • Baranowski MLH & al.
  • J Am Acad Dermatol
  • 1 juin 2019

  • Par Brian Richardson, PhD
  • Résumés d'articles
L'accès à l'intégralité du contenu de ce site est reservé uniquement aux professionnels de santé disposant d'un compte. L'accès à l'intégralité du contenu de ce site est reservé uniquement aux professionnels de santé disposant d'un compte.

Takeaway

  • In analysis stratified by insurance status, patients with melanoma experience significant variation in time to surgery, which is associated with age, sex, race, education level, comorbidity, stage, and location.

Why this matters

  • Treatment delays can negatively affect survival outcomes.

Key results

  • In patients with private insurance, age ≥50 years (P<.0001 male sex nonwhite race area and proximity to hospital income with of residents without high school degree advanced stage for ii p iii head location were associated longer surgical interval.>
  • In patients without private insurance, age 70 years), female sex (P=.0007), nonwhite race (P<.0001 area and proximity to hospital income with of residents without high school degree charlson-deyo comorbidity score advanced stage for ii head location were associated longer surgical interval.>

Study design

  • 213,146 patients with stage I/II/III cutaneous melanoma in the National Cancer Database were analyzed for factors associated with time between diagnosis and surgery.
  • Funding: Winship Cancer Institute of Emory University; NIH.

Limitations

  • Income and education estimated from Zip code.
  • Observational study of large database.